Cure vs. Treatment
A monopolistic drug company would actually prefer to produce a one-off cure over ongoing treatments, as it would lead to higher profits despite the upfront cost. Consumers could manage payments through installment plans or loans, allowing the company to still earn significant revenue. Ultimately, a self-interested firm would find more financial benefit in offering a cure rather than suppressing it.In this clip
From this podcast
The Science of Everything Podcast
Episode 5: Corporate Conspiracies
Related Questions